[ad_1] Imaging Contract Analysis Group (iCRO) from Bayer providing tailor-made providers that can span your entire imaging examine cycle from idea to completionSupporting early analysis by Section IV trials and Software program as a Medical Gadget (SaMD) growth for pharmaceutical, biotech, medical gadget, and digital well being corporations25+ years of experience because the Imaging Core Lab for Bayer, supporting greater than 200 medical trials globallyBayer can be showcasing Centafore, its providers and know-how at this 12 months’s Annual Assembly of the American Society of Scientific Oncology (ASCO) in Chicago from Could 30 until June 3 WHIPPANY, N.J.–(BUSINESS WIRE)–Bayer right this moment introduced the launch of its Imaging Core Lab Companies below the model identify Centafore. With over 25 years of expertise supporting greater than 200 medical trials at Bayer and its arm’s size corporations globally, Centafore is now positioned as a definite Imaging answer supplier, providing tailor-made providers for exterior clients to assist their medical trials and Software program as a Medical Gadget (SaMD) growth throughout various therapeutic areas and growth phases. Attendees of the 2025 Annual Assembly of the American Society of Scientific Oncology (ASCO) will get the prospect to be taught extra concerning the Centafore staff, know-how and its providers in Chicago from Could 30 until June 3 (Sales space #24152). Centafore offers know-how and providers for picture administration, processing, and interpretation, empowering examine sponsors with knowledgeable venture administration and facilitating superior analyses of imaging knowledge. Its intensive community contains skilled imaging professionals like board-certified radiologists, enabling clients to successfully handle research throughout greater than 50 international locations. “Centafore represents a major leap ahead in our dedication to enhancing the panorama of medical trial imaging and advancing the event of recent medicines and healthcare options,” mentioned Nelson Ambrogio, President of Radiology at Bayer. “By leveraging our intensive expertise and experience, we're devoted to offering our clients with top quality imaging providers that meet their particular wants in medical analysis. Via Centafore, we goal to reinforce the reliability of trial outcomes and assist knowledgeable decision-making within the growth of investigational medicines, finally benefiting sufferers and enhancing their high quality of care.” Centafore’s providers assist a variety of therapeutic areas, together with oncology, cardiovascular, CNS, dermatology, girls’s well being, pediatrics, and digital well being. It goals to assist pharmaceutical, biotech, medical gadget and digital well being corporations with early analysis by Section IV trials and SaMD growth, and adherence to regulatory and knowledge privateness compliance requirements. As a part of Bayer’s ongoing efforts to assist international healthcare startups, the Imaging Core Lab Companies of Bayer have been first introduced at ECR 2024. Centafore is already collaborating with organizations equivalent to OBIO® and Luxsonic Applied sciences to leverage medical imaging as a essential software for enhancing decision-making in medical trials and software program as a medical gadget (SaMD) growth. About Centafore Centafore is an Imaging Contract Analysis Group (iCRO) that helps early analysis by section IV trials and Software program as a Medical Gadget (SaMD) growth for pharma, biotech, medical gadget and digital well being corporations. For over 25 years, it has been the first, trusted iCRO for Bayer, taking part in a significant position in advancing the corporate’s drug pipeline – and now, prolonged its experience to exterior clients below the model identify Centafore, delivering high-quality assist for imaging research and analysis initiatives throughout the business. About Bayer in Radiology Constructing on a century of experience, Bayer is dedicated to revolutionary merchandise and high-quality providers in diagnostic imaging to reinforce affected person care. Its main radiology portfolio options distinction brokers and units for exact administration throughout modalities together with computed tomography (CT), X-ray and magnetic resonance imaging (MRI), and positron emission tomography (PET). Bayer’s complete choices additionally embody informatics options, a curated market with digital and synthetic intelligence (AI) enabled purposes. In 2024, Bayer’s radiology merchandise generated €2.1 billion in international gross sales. Dedicated to analysis and innovation, Bayer continues to advance medical imaging with the final word aim to enhance affected person outcomes. About Bayer Bayer is a world enterprise with core competencies within the life science fields of well being care and vitamin. According to its mission, “Well being for all, Starvation for none,” the corporate’s services and products are designed to assist folks and the planet thrive by supporting efforts to grasp the foremost challenges introduced by a rising and getting older international inhabitants. Bayer is dedicated to driving sustainable growth and producing a optimistic influence with its companies. On the identical time, the Group goals to extend its incomes energy and create worth by innovation and progress. The Bayer model stands for belief, reliability and high quality all through the world. In fiscal 2024, the Group employed round 93,000 folks and had gross sales of 46.6 billion euros. R&D bills amounted to six.2 billion euros. For extra data, go to www.bayer.com. Discover extra data at https://pharma.bayer.com/Observe us on LinkedIn: Bayer | Prescription drugsObserve us on Twitter: @BayerPharma Ahead-Trying Statements This launch could include forward-looking statements primarily based on present assumptions and forecasts made by Bayer administration. Numerous identified and unknown dangers, uncertainties and different elements might result in materials variations between the precise future outcomes, monetary state of affairs, growth or efficiency of the corporate and the estimates given right here. These elements embody these mentioned in Bayer’s public reviews which can be found on the Bayer web site at www.bayer.com. The corporate assumes no legal responsibility in anyway to replace these forward-looking statements or to evolve them to future occasions or developments. Contacts World media contact:Simone Leyendecker, cellphone +49 174 9508190E mail: simone.leyendecker@bayer.com US media contact:Jennifer Could, cellphoneE mail: jennifer.could@bayer.com [ad_2]
